(lp0
S'TearLab Corp  Stock Rating Upgraded by Zacks Investment Research Chaffey Breeze - 17 hours ago TearLab Corp logo TearLab Corp  was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report released on Thursday.The The Rodman &amp; Renshaw Reaffirms Buy Rating for TearLab Corp  - Petro Global News 24TearLab Corporation  Reviewed By Analysts - The De Soto Edge'
p1
aS'Why TearLab Corp. Shares Dipped Motley Fool - Nov 13, 2013 What: Shares of TearLab , an ophthalmic  medical device company focused on helping diagnose dry eye disease, dipped as much as 11% after the company reported its third-quarter earnings results.'
p2
aS'Analyst Activity  Rodman &amp; Renshaw Raises Its Price Target On TearLab Corp ... Market Exclusive - Mar 10, 2017 Today, Rodman &amp; Renshaw raised its price target on TearLab Corp  to per share. There are 1 hold rating, 2 buy ratings, 1 strong buy rating on the stock.TearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results - Yahoo FinanceTearLab Corp  Releases Earnings Results, Beats Expectations By $0.09 EPS - Chaffey Breeze'
p3
aS"TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 ... GlobeNewswire  - Nov 7, 2016 SAN DIEGO, Nov. 07, 2016  -- TearLab Corporation    today reported its consolidated financial results for the third quarter and nine months ended September 30, 2016.TearLab's  CEO Seph Jensen on Q3 2016 Results - Earnings Call Transcript - Seeking Alpha"
p4
aS'TearLab Corp. MarketWatch - Dec 21, 2009 TearLab Corp. NASDAQ: TEAR. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p5
aS'Investor Review: Focusing in on Shares of TearLab Corp  Davidson Register - 15 hours ago Active traders have a wide variety of technical indicators at their disposal for completing technical stock analysis. Presently, the 14-day ATR for TearLab Corp  is spotted at 0.52. First developed by J. Welles Wilder, the ATR may assist traders ...'
p6
aS'TearLab Corporation Comments on Shire plc FDA Approval of Xiidra ... GlobeNewswire  - Jul 12, 2016 SAN DIEGO, July 12, 2016  -- TearLab Corporation   , a company that develops and markets point of care ophthalmic in-vitro diagnostics, today recognized Shire plc on its recent&nbsp;...'
p7
aS'TearLab Corp  Cut to Sell at Zacks Investment Research Chaffey Breeze - Mar 13, 2017 Zacks Investment Research lowered shares of TearLab Corp  from a hold rating to a sell rating in a research report report published on Wednesday morning.TearLab Corp  Issues Earnings Results, Beats Expectations By $0.09 EPS - The Cerbat GemThe TearLab Corp  Posts Quarterly Earnings Results, Beats Expectations ... - Petro Global News 24'
p8
aS"Why This Analyst Sees TearLab Shares Tripling Benzinga - Jul 12, 2016 Rodman &amp; Renshaw's Raghuram Selvaraju mentioned that TearLab Corp 's Osmolarity System for the diagnosis of dry eye disease  is the first and only objective DED diagnostic test in the U.S."
p9
aS'TearLab Corp  Upgraded to Hold at Zacks Investment Research The Cerbat Gem - Mar 17, 2017 TearLab Corp logo Zacks Investment Research upgraded shares of TearLab Corp  from a sell rating to a hold rating in a report released on Thursday morning.The Rodman &amp; Renshaw Reaffirms Buy Rating for TearLab Corp  - Petro Global News 24TearLab Corp Forecasted to Post FY2017 Earnings of  Per Share  - BBNS'
p10
a.